日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reduction of CD11b(+) myeloid suppressive cells augments anti-neuroblastoma immune response induced by the anti-GD(2) antibody ch14.18/CHO.

CD11b(+)髓系抑制细胞的减少增强了抗GD(2)抗体ch14.18/CHO诱导的抗神经母细胞瘤免疫反应

Siebert Nikolai, Zumpe Maxi, von Lojewski Leon, Troschke-Meurer Sascha, Marx Madlen, Lode Holger N

Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial

HACA对ch14.18/CHO长期输注白细胞介素-2后免疫调节和治疗毒性的影响:SIOPEN II期试验结果

Siebert, Nikolai; Troschke-Meurer, Sascha; Marx, Madlen; Zumpe, Maxi; Ehlert, Karoline; Gray, Juliet; Garaventa, Alberto; Manzitti, Carla; Ash, Shifra; Klingebiel, Thomas; Beck, James; Castel, Victoria; Valteau-Couanet, Dominique; Loibner, Hans; Ladenstein, Ruth; Lode, Holger N

Platelet activation parameters and platelet-leucocyte-conjugate formation in glioblastoma multiforme patients

多形性胶质母细胞瘤患者的血小板活化参数和血小板-白细胞结合物形成

Marx, Sascha; Splittstöhser, Maximilian; Kinnen, Frederik; Moritz, Eileen; Joseph, Christy; Paul, Sebastian; Paland, Heiko; Seifert, Carolin; Marx, Madlen; Böhm, Andreas; Schwedhelm, Edzard; Holzer, Kerstin; Singer, Stephan; Ritter, Christoph A; Bien-Möller, Sandra; Schroeder, Henry W S; Rauch, Bernhard H